![Do Bad Viruses Always Become Good Guys in the End? | Office for Science and Society - McGill University Do Bad Viruses Always Become Good Guys in the End? | Office for Science and Society - McGill University](https://www.mcgill.ca/oss/files/oss/styles/hd/public/viruses_banner_image.jpeg?itok=CsFFRzm-×tamp=1639779239)
Do Bad Viruses Always Become Good Guys in the End? | Office for Science and Society - McGill University
![The life and tragic death of John Eyers – a fitness fanatic who refused the vaccine | Vaccines and immunisation | The Guardian The life and tragic death of John Eyers – a fitness fanatic who refused the vaccine | Vaccines and immunisation | The Guardian](https://i.guim.co.uk/img/media/c35b58a315279059adb8fa862628edac1fe46089/0_0_1200_720/master/1200.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=91b6009e10386343e7e7ceb3b8f76b98)
The life and tragic death of John Eyers – a fitness fanatic who refused the vaccine | Vaccines and immunisation | The Guardian
![Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study - The Lancet Diabetes & Endocrinology Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/asset/d177bda4-522d-44ad-bc09-1e96cafc279c/gr1.jpg)
Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study - The Lancet Diabetes & Endocrinology
![Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression - The Lancet Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression - The Lancet](https://www.thelancet.com/cms/asset/2705a7c4-d999-40f8-978d-76de67000e5d/gr1.jpg)
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression - The Lancet
![Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging](https://www.thelancet.com/cms/attachment/0798a6da-9607-4b92-8933-b5b700f55ad5/gr1.jpg)